Scott Eblen to Antineoplastic Agents
This is a "connection" page, showing publications Scott Eblen has written about Antineoplastic Agents.
Connection Strength
0.977
-
Targeting Chromatin Remodeling for Cancer Therapy. Curr Mol Pharmacol. 2019; 12(3):215-229.
Score: 0.369
-
Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes. Adv Cancer Res. 2018; 138:99-142.
Score: 0.348
-
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 2014 May; 35(5):1100-9.
Score: 0.261